Laxminarayan Bhat
2020
In 2020, Laxminarayan Bhat earned a total compensation of $248K as Chief Executive Officer and President at REVIVA PHARMACEUTICALS HOLDINGS.
Compensation breakdown
| Salary | $247,952 |
|---|---|
| Total | $247,952 |
Bhat received $248K in salary, accounting for 100% of the total pay in 2020.
Rankings
In 2020, Laxminarayan Bhat's compensation ranked 12,379th out of 13,090 executives tracked by ExecPay. In other words, Bhat earned more than 5.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,379 out of 13,090 | 5th |
Division Manufacturing | 5,310 out of 5,621 | 6th |
Major group Chemicals And Allied Products | 2,151 out of 2,254 | 5th |
Industry group Drugs | 1,869 out of 1,954 | 4th |
Industry Pharmaceutical Preparations | 1,391 out of 1,459 | 5th |
Source: SEC filing on October 11, 2022.
Bhat's colleagues
We found two more compensation records of executives who worked with Laxminarayan Bhat at REVIVA PHARMACEUTICALS HOLDINGS in 2020.